Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas N O'Connell

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2008
Comparison of LC-NMR and conventional NMR for structure elucidation in drug metabolism studiesGregory S Walker, Thomas N O'Connell
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes p450, and monoamine oxidasesDeepak K Dalvie, Thomas N O'Connell
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2009
Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound dispositionChristopher L Shaffer, Mithat Gunduz, Tim F Ryder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 6, 2005
Biotransformation of a GABAA receptor partial agonist in sprague-dawley rats and cynomolgus monkeys: identification of two unique N-carbamoyl metabolitesChristopher L Shaffer, Mithat Gunduz, Thomas N O'Connell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 3, 2009
Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metaboliteChristopher L Shaffer, Tim F Ryder, Karthik Venkatakrishnan, et al.
Analytical Chemistry|July 18, 2014
Solution-based indirect affinity selection mass spectrometry--a general tool for high-throughput screening of pharmaceutical compound librariesThomas N O'Connell, Jason Ramsay, Steven F Rieth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 2005
Identification of a novel glutathione adduct of diclofenac, 4'-hydroxy-2'-glutathion-deschloro-diclofenac, upon incubation with human liver microsomesLi J Yu, Yue Chen, Michael P Deninno, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humansAmin Kamel, R Scott Obach, Kevin Colizza, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 14, 2005
Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitroR Scott Obach, Anne E Reed-Hagen, Suzanne S Krueger, et al.
Journal of Medicinal Chemistry|May 29, 2013
Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a toolMarina Shalaeva, Giulia Caron, Yuriy A Abramov, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2008
Comparison of LC-NMR and conventional NMR for structure elucidation in drug metabolism studiesGregory S Walker, Thomas N O'Connell
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes p450, and monoamine oxidasesDeepak K Dalvie, Thomas N O'Connell
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2009
Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound dispositionChristopher L Shaffer, Mithat Gunduz, Tim F Ryder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 6, 2005
Biotransformation of a GABAA receptor partial agonist in sprague-dawley rats and cynomolgus monkeys: identification of two unique N-carbamoyl metabolitesChristopher L Shaffer, Mithat Gunduz, Thomas N O'Connell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 3, 2009
Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metaboliteChristopher L Shaffer, Tim F Ryder, Karthik Venkatakrishnan, et al.
Analytical Chemistry|July 18, 2014
Solution-based indirect affinity selection mass spectrometry--a general tool for high-throughput screening of pharmaceutical compound librariesThomas N O'Connell, Jason Ramsay, Steven F Rieth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 2005
Identification of a novel glutathione adduct of diclofenac, 4'-hydroxy-2'-glutathion-deschloro-diclofenac, upon incubation with human liver microsomesLi J Yu, Yue Chen, Michael P Deninno, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humansAmin Kamel, R Scott Obach, Kevin Colizza, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 14, 2005
Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitroR Scott Obach, Anne E Reed-Hagen, Suzanne S Krueger, et al.
Journal of Medicinal Chemistry|May 29, 2013
Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a toolMarina Shalaeva, Giulia Caron, Yuriy A Abramov, et al.
Pageof 2